Hansa Biopharma AB
STO:HNSA

Watchlist Manager
Hansa Biopharma AB Logo
Hansa Biopharma AB
STO:HNSA
Watchlist
Price: 32.04 SEK -2.2% Market Closed
Market Cap: 3.3B SEK

Intrinsic Value

The intrinsic value of one HNSA stock under the Base Case scenario is hidden SEK. Compared to the current market price of 32.04 SEK, Hansa Biopharma AB is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

HNSA Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Hansa Biopharma AB

Intrinsic Value History
Dive into the past to invest in the future

HNSA looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if HNSA is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about HNSA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HNSA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hansa Biopharma AB.

Explain Valuation
Compare HNSA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HNSA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hansa Biopharma AB

Current Assets 464.1m
Cash & Short-Term Investments 252.1m
Receivables 208.5m
Other Current Assets 3.5m
Non-Current Assets 277m
PP&E 11.5m
Intangibles 265.4m
Current Liabilities 419.7m
Accrued Liabilities 126.8m
Other Current Liabilities 292.9m
Non-Current Liabilities 882.2m
Long-Term Debt 775.7m
Other Non-Current Liabilities 106.5m
Efficiency

Free Cash Flow Analysis
Hansa Biopharma AB

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hansa Biopharma AB

Revenue
178.6m SEK
Cost of Revenue
-72.4m SEK
Gross Profit
106.2m SEK
Operating Expenses
-652.2m SEK
Operating Income
-546m SEK
Other Expenses
-95.2m SEK
Net Income
-641.1m SEK
Fundamental Scores

HNSA Profitability Score
Profitability Due Diligence

Hansa Biopharma AB's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Hansa Biopharma AB's profitability score is hidden . The higher the profitability score, the more profitable the company is.

HNSA Solvency Score
Solvency Due Diligence

Hansa Biopharma AB's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
hidden
Solvency
Score

Hansa Biopharma AB's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HNSA Price Targets Summary
Hansa Biopharma AB

Wall Street analysts forecast HNSA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HNSA is 79.71 SEK with a low forecast of 33.33 SEK and a high forecast of 116.55 SEK.

Lowest
Price Target
33.33 SEK
4% Upside
Average
Price Target
79.71 SEK
149% Upside
Highest
Price Target
116.55 SEK
264% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Hansa Biopharma AB
does not pay dividends
Shareholder Yield

Current shareholder yield for HNSA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one HNSA stock?

The intrinsic value of one HNSA stock under the Base Case scenario is hidden SEK.

Is HNSA stock undervalued or overvalued?

Compared to the current market price of 32.04 SEK, Hansa Biopharma AB is hidden .

Back to Top